4//SEC Filing
O'Reilly Kevin 4
Accession 0001127602-21-013912
CIK 0000203527other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 7:50 PM ET
Size
24.7 KB
Accession
0001127602-21-013912
Insider Transaction Report
Form 4
O'Reilly Kevin
SVP, President of Oncology Sys
Transactions
- Disposition to Issuer
Common Stock
2021-04-15−1,556→ 0 total - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$112.82/sh−2,587$291,865→ 0 totalExercise: $64.68Exp: 2025-02-08→ Common Stock (2,587 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−506→ 0 total→ Common Stock (506 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−1,059→ 0 total→ Common Stock (1,059 underlying) - Disposition to Issuer
Performance Shares
2021-04-15−1,641→ 0 total→ Common Stock (1,641 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−6,340→ 0 total→ Common Stock (6,340 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$131.77/sh−6,859$903,810→ 0 totalExercise: $45.73Exp: 2026-02-14→ Common Stock (6,859 underlying) - Disposition to Issuer
Performance Shares
2021-04-15−1,711→ 0 total→ Common Stock (1,711 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$146.91/sh−7,846$1,152,656→ 0 totalExercise: $30.59Exp: 2027-02-13→ Common Stock (7,846 underlying)
Footnotes (12)
- [F1]Amount of securities disposed of reflect 74 shares purchased on April 8, 2021 and 86 shares purchased on October 30, 2020 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan.
- [F10]Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
- [F11]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
- [F12]Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
- [F2]Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
- [F3]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
- [F4]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.
- [F5]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
- [F6]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
- [F7]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
- [F8]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
- [F9]Each performance stock unit represents a contingent right to receive one share of VAR common stock.
Documents
Issuer
VARIAN MEDICAL SYSTEMS INC
CIK 0000203527
Entity typeother
Related Parties
1- filerCIK 0001826572
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 7:50 PM ET
- Size
- 24.7 KB